Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
03/2001
03/07/2001EP0915935B1 4,7-dichlororhodamine dyes
03/07/2001CN1286247A Process for preparing prolycopene and its intermediate
03/07/2001CN1286245A Stable (CF3)2N(-) salt and preparing process thereof
03/07/2001CN1062855C Method for preparing alkali metal salt of hydroxymethyl-iminodiacetic acid
03/06/2001US6197986 Compounds containing biologically active silicon, which are under solid form
03/06/2001US6197984 Method for the preparation of copolymers of ethylene/norbornene-type monomers with nickel catalysts
03/06/2001US6197825 Azulenyl nitrone spin trapping agents, methods of making and using same
03/06/2001US6197809 Doxorubicin antibiotic
03/06/2001US6197785 Cardiovascular disorders
03/06/2001US6197777 Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides
03/06/2001US6197775 Viricides
03/06/2001US6197766 Controlling plant insects
03/06/2001US6197760 Isophosphoramide mustard analogs and use thereof
03/06/2001US6197759 Osteoblast-specific mitogens and drugs containing such compounds
03/06/2001US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
03/06/2001US6197555 Nucleotide compounds including a rigid linker
03/06/2001US6197513 PNA and DNA conjugates and methods for preparation thereof
03/06/2001CA1341201C Bis-(hydroxymethyl) cyclobutyl purines and pyrimidines
03/01/2001WO2001014390A2 METABOTROPIC GLUTAMATE RECEPTOR LIGAND DERIVATIVES AS NAALADase INHIBITORS
03/01/2001WO2001014315A1 Aminohydroxylation of olefins
03/01/2001WO2001014299A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions
03/01/2001WO1999043314A9 Farnesyl-protein transferase inhibitors
03/01/2001CA2382779A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions
03/01/2001CA2317284A1 Stable (cf3)2n-salts and process for preparing them
02/2001
02/28/2001EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient
02/28/2001EP1077982A1 Method for the manufacture of n - phosphonomethylglycine from n - phosphonomethyliminodiacetic acid using a catalytic carbon
02/28/2001EP1077970A1 11-aryl-benzo(b)naphtho(2,3-d)furans and 11-aryl-benzo(b)naphtho(2,3-d)thiophenes useful in the treatment of insulin resistance and hyperglycemia
02/28/2001EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
02/28/2001EP1077925A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
02/28/2001EP1027358A4 Anhydrous mononuclear tris(beta-diketonate) bismuth compositions for deposition of bismuth-containing films, and method of making the same
02/27/2001US6194605 Process for preparing aluminum salts of dialkylphosphinic acids and diphosphinic acids
02/27/2001US6194593 1, 2-bis(dialkylphosphino) benzene derivates having optical activites, process for producing same, and rhodium metal complexes containing same as ligands
02/27/2001US6194453 Antiinflammatory agents; therapy for immunology conditions
02/27/2001US6194438 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one, and compositions and methods for inhibiting abnormal cell growth comprising said derivatives
02/27/2001US6194398 Phosphonate nucleotide compound
02/27/2001US6194397 Enzyme inhibitors of acetylcholinesterase and butyrylcholinesterase; increased hepatoprotective and antienzyme activities; n'-substituted phosphonoalkyl-, phosphono- or thiophosphonocytisines
02/22/2001WO2001012838A2 Compounds which modulate the activity of an lpa receptor
02/22/2001WO2001012640A1 Method for the production of phosphonomethylglycine
02/22/2001WO2001012639A1 Method for the production of phosphonomethylglycin
02/22/2001WO2001012638A1 Method of purifying organic phosphoric ester
02/22/2001WO2001012637A1 Transition metal complexes comprising .beta.-diiminate ligands and processes for polymerizing olefins
02/22/2001WO2001012604A1 Fungicides
02/22/2001WO2001012584A2 Pharmaceutical compounds
02/22/2001WO2001012579A2 New stilbenes with vascular damaging activity
02/22/2001WO2001012574A1 Transfer hydrogenation process
02/22/2001DE19938622A1 Pure N-phosphonomethyl-glycine preparation in high yield for use as herbicide, by peroxide oxidation of N-(phosphonomethyl)-iminodiacetic acid over activated carbon catalyst having specific particle size distribution
02/22/2001CA2698353A1 Pharmaceutical compounds
02/22/2001CA2387651A1 Transition metal complexes comprising .beta.-diiminate ligands and processes for polymerizing olefins
02/22/2001CA2383266A1 Transfer hydrogenation process
02/22/2001CA2381413A1 Method for the production of phosphonomethylglycine
02/22/2001CA2381412A1 Method for the production of phosphonomethylglycin
02/22/2001CA2381409A1 Nitric ester derivatives
02/22/2001CA2379544A1 New stilbenes with vascular damaging activity
02/21/2001EP1077066A1 Preventives/remedies for skin diseases
02/21/2001EP1076660A1 Substituted (4-brompyrazole-3-yl)benzazoles
02/21/2001EP0874796B1 Improved metal-ligand complex catalyzed processes
02/21/2001EP0809628B1 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on dicarboxylic acid diamides
02/21/2001CN1284960A 'Pi' complex compounds
02/21/2001CN1284897A Batch devices for reduction of compounds from biological compositions containing cells and methods of use
02/21/2001CN1284896A Flow device for the reduction of compounds from biological compositions and methods of use
02/21/2001CN1284508A Synthesis process of aryloxy cyclotrinitrile phosphide
02/21/2001CN1284507A Process for preparation of N-alkyl-hydroxy amino-methyl-phophonic acid or its salt
02/20/2001US6191298 A simple, one-step reaction process to produce the title ester by the reaction of an acetylenic compound and a phosphorothioate ester in the presence of a palladium complex catalyst; chemical intermediates
02/20/2001US6191284 Ligands and complexes for enantioselective hydrogenation
02/20/2001US6191276 Method for preparing sterically hindered phosphoramidates
02/20/2001US6191241 Method for producing high melting-point polyolefins
02/20/2001US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
02/20/2001US6191123 Organic-arsenic compounds
02/20/2001US6191063 Polyoxyalkylated aryl phosphine-rhodium complex catalyst; efficiency/selectivity for conversion of higher molecular weight olefin starting materials
02/20/2001US6190679 Storage stability; feel
02/20/2001CA2084036C Use of specific counteranions to modify the solubility of tetrazolium salts
02/20/2001CA2044418C Aminoalkylphosphinates and phosphinic-acid-containing polymers therefrom
02/20/2001CA2022811C Phosphorus compounds
02/15/2001WO2001010874A1 Process for producing 4-amino-1-hidroxybutylidene-1,1-bisphosphonic acid and its trihydrated monosodic salt
02/15/2001WO2001010873A1 Novel 2-decarboxy-2-phosphinico prostaglandin f analogs
02/15/2001WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
02/15/2001WO2000053313A3 Lanthanide catalysts for synthesis of compounds and combinatorial libraries
02/15/2001WO2000052015A3 Novel phosphorus-containing prodrugs
02/14/2001EP1075489A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
02/14/2001EP1075482A1 Cationic ruthenium complexes, their production and their use
02/14/2001EP1075481A1 Monomeric, oligomeric and polymeric knoevenagel condensation products
02/14/2001EP1075472A1 Prodrugs of benzofuranylmethyl carbamate nk 1? antagonists
02/14/2001EP1021451A4 Asymmetric synthesis and catalysis with chiral heterocyclic compounds
02/14/2001EP0711294B1 Use of diazapentalene derivatives as reagents specific for thiol compounds
02/14/2001EP0708767B1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives
02/14/2001CN1284072A Prodrugs of aspartyl protease inhibitors
02/14/2001CN1284071A Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors
02/14/2001CN1284060A Novel metalloproteinase inhibitors
02/14/2001CN1061982C Process for mfg. N-phosphonomethylglycine
02/14/2001CN1061981C Process for preparing N-phosphonomethylamino carboxylic acids
02/14/2001CN1061980C Process for preparing N-phopshonomethylamino carboxylic acids
02/13/2001US6187959 Preparation of phosphonium salts
02/13/2001US6187955 Guanidine derivatives and process for their production
02/13/2001US6187953 A guanidinium phosphines use as catalyst ligands for the carbon-carbon linkage reactions
02/13/2001US6187941 Process for the preparation of oxazaphosphorine-2-amines
02/13/2001US6187922 Process for the preparation of purine derivatives
02/13/2001US6187919 Ultraviolet absorbers
02/13/2001US6187913 Covalently crosslinked oligonucleotides, preparation method and synthon which is of use in the method
02/13/2001US6187910 Chelation compounds, radionuclide metal chelate compounds and radiolabeled targeting moieties formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic use
02/13/2001US6187871 Electron acceptor compositions on polymer templates